Advertisement

The method of averaging applied to pharmacokinetic/pharmacodynamic indirect response models

  • Adrian Dunne
  • Willem de Winter
  • Chyi-Hung Hsu
  • Shiferaw Mariam
  • Martine Neyens
  • José Pinheiro
  • Xavier Woot de Trixhe
Original Paper

Abstract

The computational effort required to fit the pharmacodynamic (PD) part of a pharmacokinetic/pharmacodynamic (PK/PD) model can be considerable if the differential equations describing the model are solved numerically. This burden can be greatly reduced by applying the method of averaging (MAv) in the appropriate circumstances. The MAv gives an approximate solution, which is expected to be a good approximation when the PK profile is periodic (i.e. repeats its values in regular intervals) and the rate of change of the PD response is such that it is approximately constant over a single period of the PK profile. This paper explains the basis of the MAv by means of a simple mathematical derivation. The NONMEM® implementation of the MAv using the abbreviated FORTRAN function FUNCA is described and explained. The application of the MAv is illustrated by means of an example involving changes in glycated hemoglobin (HbA1c%) following administration of canagliflozin, a selective sodium glucose co-transporter 2 inhibitor. The PK/PD model applied to these data is fitted with NONMEM® using both the MAv and the standard method using a numerical differential equation solver (NDES). Both methods give virtually identical results but the NDES method takes almost 8 h to run both the estimation and covariance steps, whilst the MAv produces the same results in less than 30 s. An outline of the NONMEM® control stream and the FORTRAN code for the FUNCA function is provided in the appendices.

Keywords

Pharmacokinetic/pharmacodynamic model Method of averaging Computational efficiency 

References

  1. 1.
    Dayneka NL, Garg V, Jusko WJ (1993) Comparison of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Biopharm 21:457–478PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Sharma A, Jusko WJ (1996) Characterization of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Pharmacodyn 24:611–635CrossRefGoogle Scholar
  3. 3.
    Krzyzanski W, Jusko WJ (1997) Mathematical formalism for the properties of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Pharmacodyn 25:107–123CrossRefGoogle Scholar
  4. 4.
    Sanders J, Verhulst F (1985) Averaging methods in nonlinear dynamical systems. Springer, New YorkCrossRefGoogle Scholar
  5. 5.
    Zhang L, Beal SL, Sheiner LB (2003) Sequential analysis for population PK/PD data I: best-case performance. J Pharmacokinet Pharmacodyn 30:387–404PubMedCrossRefGoogle Scholar
  6. 6.
    Beal SL, Sheiner LB, .Boeckmann A, Bauer RJ (2009) NONMEM user’s guides (1989-2009), Icon Development Solutions, Ellicott CityGoogle Scholar
  7. 7.
    Hoeben E, Vermeulen A, deWinter W, Neyens M, Devineni D, Dunne (2015) A Population pharmacokinetic modeling of canagliflozin in healthy volunteers and patients with Type 2 diabetes mellitus. Submitted to Clinical Pharmacokinetics Google Scholar
  8. 8.
    Hindmarsh AC (1983) ODEPACK, a systematized collection of ODE solvers. In: Stepleman RS et al (eds) IMACS transactions on scientific computation, vol 1. North-Holland, Scientific Computing, pp 55–64Google Scholar
  9. 9.
    Butcher JC (1987) The numerical analysis of ordinary differential equations: Runge-Kutta and general linear methods. Wiley, New YorkGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Adrian Dunne
    • 1
    • 3
  • Willem de Winter
    • 1
  • Chyi-Hung Hsu
    • 2
  • Shiferaw Mariam
    • 2
  • Martine Neyens
    • 1
  • José Pinheiro
    • 2
  • Xavier Woot de Trixhe
    • 1
  1. 1.Model Based Drug DevelopmentJanssen Research & Development, A Division of Janssen Pharmaceutica NVBeerseBelgium
  2. 2.Model Based Drug DevelopmentJanssen Research & Development LLCRaritanUSA
  3. 3.Taca TrainingDublinIreland

Personalised recommendations